# A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test

> **NCT04529122** · — · RECRUITING · sponsor: **Hoffmann-La Roche** · enrollment: 15000 (estimated)

## Conditions studied

- Solid Tumours

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04529122
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-08-27
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 15000 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04529122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04529122, "A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04529122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*